Cerity Partners
EDIT icon

Cerity Partners’s Editas Medicine EDIT Stock Holding History

Cerity Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
56,132
+11,052
+25% +$32.3K ﹤0.01% 3075
2026
Q1 		$111K Buy
+45,080
New +$95.4K ﹤0.01% 3007
2025
Q4 		– Sell
-14,339
Closed -$49.8K – 2915
2025
Q3 		$49.8K Sell
14,339
-693
-5% -$1.93K ﹤0.01% 2696
2025
Q2 		$33.1K Sell
15,032
-34,028
-69% -$55.7K ﹤0.01% 2579
2025
Q1 		$56.9K Buy
+49,060
New +$72.2K ﹤0.01% 2384
2024
Q4 		– Sell
-19,597
Closed -$66.8K – 2472
2024
Q3 		$66.8K Buy
+19,597
New +$85.3K ﹤0.01% 2465

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Cerity Partners's EDIT Position: Q2 2026 in Review

Cerity Partners increased its Editas Medicine (EDIT) stake by 25% in Q2 2026, buying an estimated $32.3K and bringing the position to 56,132 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3075.

Cerity Partners first reported a position in EDIT in Q3 2024 and has held it in 6 quarters since. 182 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Cerity Partners held 56,132 shares of Editas Medicine worth $182K as of Q2 2026.
  • Cerity Partners bought 11,052 Editas Medicine shares in Q2 2026, an estimated $32.3K.
  • Editas Medicine made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3075 holding.
  • Cerity Partners first reported a position in Editas Medicine in Q3 2024 and has held it in 6 quarters since.
  • 182 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.